Innate immune cells link dietary cues to normal and abnormal metabolic regulation
Nature Immunology,
Journal Year:
2025,
Volume and Issue:
26(1), P. 29 - 41
Published: Jan. 1, 2025
Language: Английский
TREM2 promotes the proliferation and invasion of renal cell carcinoma cells by inhibiting the P53 signaling pathway
Liang Zhang,
No information about this author
Zhong Lv,
No information about this author
Qin‐Yu Xu
No information about this author
et al.
Oncology Letters,
Journal Year:
2024,
Volume and Issue:
28(5)
Published: Sept. 6, 2024
Renal
cell
carcinoma
(RCC)
is
a
prevalent
malignancy
characterized
by
poor
prognosis
and
high
mortality.
The
role
of
triggering
receptor
expressed
on
myeloid
cells-2
(TREM2)
in
RCC
progression
has
been
increasingly
recognized,
yet
its
underlying
mechanisms
remain
to
be
fully
elucidated.
aim
the
present
study
was
assess
effects
TREM2
cells
potential
mechanisms.
Lentiviral
transfection
used
knockdown
overexpress
cells,
expression
level
evaluated
using
reverse
transcription-quantitative
PCR.
Cell
Counting
Kit-8
(CCK-8)
5-ethynyl-2'-deoxyuridine
(EdU)
assays
were
proliferation
cells.
migration
invasion
wound
healing
assay
Transwell
assay,
respectively.
Western
blotting
levels
TREM2,
P53,
p-P53,
P21
p-P21
or
overexpression
results
demonstrated
that
significantly
higher
cancer
tissues
compared
with
adjacent
normal
tissues.
CCK-8
EdU
inhibited
whilst
enhanced
revealed
that,
control
group,
increased
whereas
decreased
In
addition,
western
phosphorylation
P53
proteins
after
conclusion,
highly
promotes
inhibiting
signaling
pathway.
provides
new
insights
into
regulatory
effect
further
reveals
as
therapeutic
target
for
RCC.
Language: Английский
TREM-1 and TREM-2 as therapeutic targets: clinical challenges and perspectives
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 16, 2024
TREM-1
and
TREM-2
as
Therapeutic
Targets:
Clinical
Challenges
Perspectives.
Language: Английский
Age-associated modulation of TREM1/2- expressing macrophages promotes melanoma progression and metastasis
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 21, 2024
Abstract
Aging
is
a
known
risk
factor
for
melanoma,
yet
mechanisms
underlying
melanoma
progression
and
metastasis
in
older
populations
remain
largely
unexplored.
Among
the
current
knowledge
gaps
how
aging
alters
phenotypes
of
cells
microenvironment.
Here
we
demonstrate
that
age
enriches
immunosuppressor
tumor
microenvironment,
which
linked
to
associated
with
metastasis.
cellular
enriched
by
were
macrophages
tolerogenic
phenotype
expressing
TREM2
dysfunctional
CD8-positive
an
exhausted
phenotype,
while
profibrotic
TREM1
depleted.
Notably,
inhibition
decreased
growth
young
but
not
old
mice,
whereas
prevented
lung
aged
mice.
These
data
identify
novel
targets
may
guide
aged-dependent
immunotherapies.
Language: Английский